Stock DRRX DURECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart DURECT Corporation

Equities

DRRX

US2666055007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.06 USD -6.19% Intraday chart for DURECT Corporation -8.62% +79.66%
Mar. 27 Transcript : DURECT Corporation, Q4 2023 Earnings Call, Mar 27, 2024
Mar. 27 DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DURECT CORPORATION Stock DURECT Corporation
 32.9M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. DRRX Stock
  4. Charts DURECT Corporation
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW